Clinical Trials
5 trialsNCT06085976 2023-10-17
Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.
Clinica Universidad de Navarra, Universidad de Navarra
Phase 2 Unknown
NCT00241020 2016-04-12
Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma
Novartis
Phase 3 Completed
NCT00257426 2012-02-14
Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT00250796 2010-01-07
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
University of New Mexico
Phase 2 Completed
NCT00386984 2006-10-12
Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma
University Hospital Freiburg
Phase 3 Completed